e7389-lf
Showing 1 - 2 of 2
Solid Tumors Trial in Japan (E7389-LF, Nivolumab)
Active, not recruiting
- Solid Neoplasms
- E7389-LF
- Nivolumab
-
Nagoya, Aichi, Japan
- +18 more
Jan 31, 2023
Solid Tumor Trial in Japan (E7389-LF)
Active, not recruiting
- Solid Tumor
- E7389-LF
-
Kashiwa, Chiba, Japan
- +11 more
Nov 28, 2022